FreeIn Brief Baylor researchers receive five-year, $5.5M NCI grant for liver cancer risk factors and prevention research August 05, 2022Vol.48 No.31
FreeIn the Archives DeVita, Marks, Zubrod: Oral histories with the people who shaped the NCA August 05, 2022Vol.48 No.31
FreeFunding Opportunities Thermo Fisher Scientific opens Oncomine Clinical Research Grant call for submissions; latest awardees announced August 05, 2022Vol.48 No.31
FreeFunding Opportunities DoD Peer Reviewed Cancer Research Program anticipated funding opportunities for the 2022 fiscal year August 05, 2022Vol.48 No.31
Clinical RoundupFree Subcutaneous formulation of Tecentriq demonstrates positive phase III results August 05, 2022Vol.48 No.31
Clinical RoundupFree Thermo Fisher introduces assays for MRD detection in myeloid malignancies August 05, 2022Vol.48 No.31
Drugs & TargetsFree Lynparza approved by the EC as adjuvant treatment for high-risk breast cancer August 05, 2022Vol.48 No.31
Drugs & TargetsFree MD Anderson and TransCode Therapeutics collaborate to advance RNA therapies August 05, 2022Vol.48 No.31
Drugs & TargetsFree Poseida, Roche to collaborate on allogeneic CAR T-cell therapies for hematologic malignancies August 05, 2022Vol.48 No.31
